Skip to main content
. 2022 Jan 8;11(1):72. doi: 10.3390/antibiotics11010072

Figure 1.

Figure 1

Active compounds TRI and PYR identified from initial screening; structure of compound C and reported active compounds similar to TRI and PYR.